Sample planning
Use a sample to test the buyer's stated acceptance questions and verify the proposed configuration—not to infer a therapeutic result or approve unrelated supplier claims. The final decision remains with the business buyer and its qualified clinical, quality or regulatory reviewers.
Define the silver-containing layer or construction being requested, overall dimensions, absorbent or contact layers, adhesive boundaries, backing, sterile or non-sterile status and any buyer-defined acceptance observations. If alternative constructions are acceptable, list them as separate comparison lines.
State sample units by configuration and how a commercial order would be counted: individual dressings, packs, inner boxes or cases. Add the US destination, expected variant mix, target timing, budget currency and whether the budget applies per unit or to the whole order.
Identify labeling drafts, material declarations, shelf-life information, packaging records, sterilization information and other exact-product documents for review. Record who reviews each item, which questions can remain open at sample stage and which must be closed before order approval.
Keep the approved brief, reference sample if one exists, measurement method, packaging expectations and review notes together. A subjective observation should name the reviewer and conditions instead of becoming a universal performance claim.
Public descriptions can suggest attributes to ask about, but they are not inventory, authorization or certification for the supplier's sample. Record the source and the limited reason it was consulted.
Ask the supplier to connect the sample, specification sheet, packaging revision and offered manufacturer. Note every deviation, alternative and missing file so that a related certificate or product-family page is not mistaken for model-specific evidence.
After review, the decision record should say accepted, rejected or conditionally held and explain why. Acceptance of appearance or dimensions does not establish clinical suitability, regulatory clearance, commercial availability or future production consistency. Those matters require the appropriate written confirmation and qualified review.